I would direct you towards this article Lfc- there was some excitement last year when Pharmaust announced that they had appointed Neville Bassett as a non-executive director. "Mr Bassett is a chartered accountant in corporate, financial and management advisory services and has experience in Australian financial markets including mergers and acquisitions."
Link to the article below:
https://www.businessnews.com.au/article/Bassett-takes-seat-on-PharmAust-board
Monepantal FDA Conditional Approval, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $95.88M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.0¢ | $106.3K | 547.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 593393 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 13456 | 2 |
View Market Depth
| Last trade - 15.22pm 12/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |